Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)

• Status: Completed
• Trial end date: 0000-00-00
• Target enrollment: 125
• Participant gender: Both

Summary

The purpose of this study is to determine the effectiveness of commercially available kefir on preventing antibiotic-associated diarrhea compared to placebo in children ages 1-5.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Georgetown University
• Collaborator: Lifeway Foods, Inc.
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular
• Last Updated: 2012-02-21

Criteria

Inclusion Criteria:

• Ability to speak and write English

• Aged 1-5 years

• Male or female

• Diagnosed with an upper respiratory infection and placed on a penicillin class antibiotic regimen for 10 days

Exclusion Criteria:

• Developmental delays

• Chronic conditions, such as diabetes or asthma, that require medication

• Prematurity, birth weight <2500 grams

• Allergy to kefir and/or milk

• Active diarrhea

• Congenital anomalies

• Failure to thrive

• Parental belief of lactose intolerance